Emma Iserman

Statistical Analyst
Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON
Hamilton, Ontario, Canada

Presentation(s):

• OC 24.1 - Effect of the type of F9 mutation on the pharmacokinetic profile of patients with hemophilia B treated with extended half-life FIX concentrates.

  Sunday, June 25, 2023
  14:45 – 15:00 ET

• OC 24.2 - Estimated Factor VIII Activity Levels at the Time of Bleeding Events in Individuals with Hemophilia A without Inhibitors

  Sunday, June 25, 2023
  15:00 – 15:15 ET

• PB0175 - Impact of reagent on the estimation of Eloctate and Adynovate pharmacokinetic (PK) parameters?

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB0644 - Evaluation of the burden of bone fractures in people living with hemophilia: a registry-based case-control study.

  Monday, June 26, 2023
  18:30 – 19:30 ET